Lupron Depot-PED (leuprolide acetate) NDC 0074-3575

NDC codes

FDA NDC Directory

Product NDC (as listed)0074-3575Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00074-3575Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0074-3575-01	00074357501	1 KIT in 1 CARTON (0074-3575-01) * 1.5 mL in 1 SYRINGE (0074-3410-01) * 2 SWAB in 1 PACKET (0074-0010-01)Marketed from Apr 14, 2023

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lupron Depot-PED
Generic name (nonproprietary): leuprolide acetate
Dosage form: Kit
Labeler: AbbVie Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020263
Marketing start: Apr 14, 2023
Listing expires: Dec 31, 2026
Identifiers: Product ID 0074-3575_24e33d5f-c64b-4d45-a5ae-e18a1f696cfaSPL ID 24e33d5f-c64b-4d45-a5ae-e18a1f696cfaSPL set ID e99f47d2-da10-3127-ecb3-e5d942ae6e81RxCUI 1115447, 1115449, 1115454, 1115456, 1946519, 1946520, 2639668, 2639669, 2639742, 2639743, 2639749, 2639750

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400074357501 followed by a unit qualifier and the quantity

Package 00074-3575-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 14, 2025.

Indications (excerpt from the label)

LUPRON DEPOT-PED is indicated for the treatment of pediatric patients with central precocious puberty (CPP). LUPRON DEPOT-PED is a gonadotropin releasing hormone (GnRH) agonist indicated for the treatment of pediatric patients with central precocious puberty. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 020263

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020263
Product	Strength	Form · route	Labeler	Product NDC
Lupron Depot-PEDleuprolide acetate	—	Kit	AbbVie Inc.	0074-2282
Lupron Depot-PEDleuprolide acetate	—	Kit	AbbVie Inc.	0074-9694
Lupron Depot-PEDleuprolide acetate	—	Kit	AbbVie Inc.	0074-2440
Lupron Depot-PEDleuprolide acetate	—	Kit	AbbVie Inc.	0074-3779
Lupron Depot-PEDleuprolide acetate	—	Kit	AbbVie Inc.	0074-2108